Abstract
Purpose
Helios belongs to Ikaros family, which plays an important role in the cell-fate decision and control cell proliferation; abnormal expressions in leukemia are associated with poor prognosis. In this study, we investigated the Helios expression between Helicobacter pylori infection and prognosis in gastric cancer patients.
Methods
A total of 67 gastric cancer patients who received partial or full gastrectomies were enrolled. Helios expression by immunohistochemistry and mRNA was investigated with the clinical stage, Helicobacter pylori infection, CD4 expression, FoxP3 expression and prognosis.
Results
From the immunohistochemistry stain, we found that the Helios was expressed in both cancer cell and tumor-infiltrated lymphocytes. The high expression of Helios in gastric tumor cells had a better median overall survival rate in gastric cancer patients (50.7 ± 3.2 vs. 34.1 ± 4.9 months; P = 0.015), Helicobacter pylori-infected patients (51.1 ± 3.5 vs. 30.4 ± 5.1 months; P = 0.007) and advanced gastric cancer patients (42.1 ± 5.5 vs. 23.2 ± 4.8 months; P = 0.043). From multivariate analysis, the Helios expression in gastric tumor cells was an independent factor to predict better survival in all gastric cancers (HR = 2.78; 95 % confidence interval [CI], 1.09–7.09; P = 0.032) and advanced gastric cancer patients (HR = 2.85; 95 % confidence interval [CI], 1.00–8.13; P = 0.03).
Conclusions
Higher expression of Helios in gastric tumor cells predicts better survival in gastric cancer patients, especially for Helicobacter pylori-infected and advanced-stage gastric cancer patients.
Similar content being viewed by others
References
Abe A, Nagatsuma AK, Higuchi Y, Nakamura Y, Yanagihara K, Ochiai A (2015) Site-specific fibroblasts regulate sitespecific inflammatory niche formation in gastric cancer. Gastric Cancer. doi:10.1007/s10120-015-0584-y
Asanuma S, Yamagishi M, Kawanami K, Nakano K, Sato-Otsubo A, Muto S et al (2013) Adult T-cell leukemia cells are characterized by abnormalities of Helios expression that promote T cell growth. Cancer Sci 104:1097–1106
Baine IU, Basu S, Ames R, Sellers RS, Macian F (2013) Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells. J Immunol 190:1008–1016
Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10:7252–7259
Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513:202–209
Charafe-Jauffret E, Tarpin C, Bardou VJ, Bertucci F, Ginestier C, Braud AC et al (2004) Immunophenotypic analysis of inflammatory breast cancers: identification of an ‘inflammatory signature’. J Pathol 202:265–273
deLeeuw RJ, Kost SE, Kakal JA, Nelson BH (2012) The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature. Clin Cancer Res 18:3022–3029
Dovat S, Montecino-Rodriguez E, Schuman V, Teitell MA, Dorshkind K, Smale ST (2005) Transgenic expression of Helios in B lineage cells alters B cell properties and promotes lymphomagenesis. J Immunol 175:3508–3515
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2012) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN. Int J Cancer 136:E359–E386
Fujii K, Ishimaru F, Nakase K, Tabayashi T, Kozuka T, Naoki K et al (2003) Over-expression of short isoforms of Helios in patients with adult T-cell leukaemia/lymphoma. Br J Haematol 120:986–989
Georgopoulos K (2002) Haematopoietic cell-fate decisions, chromatin regulation and ikaros. Nat Rev Immunol 2:162–174
Getnet D, Grosso JF, Goldberg MV, Harris TJ, Yen HR, Bruno TC et al (2010) A role for the transcription factor Helios in human CD4[+]CD25[+] regulatory T cells. Mol Immunol 47:1595–1600
Hahm K, Cobb BS, McCarty AS, Brown KE, Klug CA, Lee R et al (1998) Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev 12:782–796
Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061
John LB, Ward AC (2011) The Ikaros gene family: transcriptional regulators of hematopoiesis and immunity. Mol Immunol 48:1272–1278
Kashimura S, Saze Z, Terashima M, Soeta N, Ohtani S, Osuka F et al (2012) CD83[+] dendritic cells and Foxp3[+] regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer. Gastric Cancer 15:144–153
Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J et al (2015) Integrated molecular analysis of adult T cell leukemia/lymphoma. Nat Genet 47:1304–1315
Kelley CM, Ikeda T, Koipally J, Avitahl N, Wu L, Georgopoulos K et al (1998) Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol 8:508–515
Kim KJ, Lee KS, Cho HJ, Kim YH, Yang HK, Kim WH et al (2014) Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. Hum Pathol 45:285–293
Kindlund B, Sjoling A, Yakkala C, Adamsson J, Janzon A, Hansson LE et al (2016) CD4 regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-beta. Gastric Cancer. doi:10.1007/s10120-015-0591-z
Martin-Ibanez R, Crespo E, Esgleas M, Urban N, Wang B, Waclaw R et al (2012) Helios transcription factor expression depends on Gsx2 and Dlx1&2 function in developing striatal matrix neurons. Stem Cells Dev 21:2239–2251
Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB et al (2009) Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 360:470–480
Ohtsu A, Shah MA, Van Cutsem E, Rha SY, Sawaki A, Park SR et al (2011) Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 29:3968–3976
Rebollo A, Schmitt C (2003) Ikaros, Aiolos and Helios: transcription regulators and lymphoid malignancies. Immunol Cell Biol 81:171–175
Shang B, Liu Y, Jiang SJ, Liu Y (2015) Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis. Sci Rep 5:15179
Takatori H, Kawashima H, Matsuki A, Meguro K, Tanaka S, Iwamoto T et al (2015) Helios enhances Treg cell function in cooperation with FoxP3. Arthritis Rheumatol 67:1491–1502
Acknowledgments
This work was supported by Chang Gung Memorial Hospital, Chiayi (Taiwan, Republic of China). We thank the Laboratory Animal Center, Department of Medical Research, Chang Gung Memorial Hospital at Chiayi; Tissue Bank, Department of Medical Research, Chang Gung Memorial Hospital at Chiayi; the EVERBIO AutoTiss 1000 tissue microarrayer service provided by the Expensive Advanced Instrument Core Laboratory, Department of Medical Research and Development, Chang Gung Memorial Hospital at Chiayi to help us in the experiments and tissue collection.
Funding
This study was funded by Chang Gung Memorial Hospital, Chia-Yi, TW. The funding number is CORPG6D0011, CORPG6D0012, CORPG6D0013, CORPG6D0021, CORPG6D0022, CORPG6D0023.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights statement
The Institutional Review Board of the Chang Gung Memorial Hospital approved all human subject assessments (IRB No. 104-4187C).
Informed consent
The pathologic examination and further investigation were carried out under the informed consent of the patients.
Rights and permissions
About this article
Cite this article
Chen, WM., Wu, CS., Liu, JL. et al. Expression of Helios in gastric tumor cells predicts better survival in gastric cancer patients. J Cancer Res Clin Oncol 142, 2375–2382 (2016). https://doi.org/10.1007/s00432-016-2223-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-016-2223-3